Welcome to the AutoGenomics Investor Relations page. We are a commercial stage molecular diagnostics company offering an innovative and proprietary technology platform to clinical reference labs, specialty clinics, and hospital laboratories. From walk-away automation to high throughput systems we enable the clinical laboratory to perform high impact genetic testing simply, accurately, and efficiently.

For investor information, please send email inquiries to mding@autogenomics.com.  

Investor Relations